This is a working overview of AOD-9604, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-09. Anything still debated is marked as such rather than presented as settled.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA under peptide hormones |
| WADA class | S2 | Peptide hormones, growth factors, related substances, and mimetics |
| Approved therapeutic use | Not established | Clinical research did not lead to broad marketing approval |
| Common detection method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| Sample preparation | Extraction and enrichment | Immunoaffinity or solid-phase extraction may be used |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
=== Heart and vascular === The SOMC Heart Care Unit is a 12-bed unit responsible for the care of adult cardiac patients and patients recovering from open heart surgery. SOMC utilizes a Universal Bed Model, in which the patient's room essentially changes throughout the open-heart procedure, starting as an intensive care recovery room on arrival from surgery and transitioning to a home-like environment with family space and amenities. Heart and Vascular services provided at SOMC include:
Guanylate cyclase (EC 4.6.1.2, also known as guanyl cyclase, guanylyl cyclase, or GC; systematic name GTP diphosphate-lyase (cyclizing; 3′,5′-cyclic-GMP-forming)) is a lyase enzyme that converts guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP) and pyrophosphate:
=== Sugar profile === Honey is mainly fructose (51% of sugars) and glucose (44%) (table), with remaining sugars including galactose, maltose, and sucrose, each supplying 3% or less of total sugars (table, USDA reference). The glycemic index of honey has a possible range of 31–78, depending on the variety. The specific composition, color, aroma, and flavor of any batch of honey depend on the flowers foraged by bees that produced the honey.
=== Nutritional value === House crickets are an incomplete protein source, deficient in tryptophan and lysine. They contain both omega-3 and omega-6 fatty acids. Despite their nutritional value, insects such as house crickets are not widely accepted as food in Western countries. Surveys have found that while many people are willing to try plant-based meat substitutes, only a small proportion would consider eating insects.
==== First-pass metabolism ==== During a typical drinking session, approximately 90% of the metabolism of ethanol occurs in the liver. Alcohol dehydrogenase and aldehyde dehydrogenase are present at their highest concentrations (in liver mitochondria). But these enzymes are widely expressed throughout the body, such as in the stomach and small intestine. Some alcohol undergoes a first pass of metabolism in these areas, before it ever enters the bloodstream.
Sources: en.wikipedia.org
Producing better protein: the evolution of T7 bacteriophages on a non-evolving E. coli strain that encoded 3-iodotyrosine on the amber codon, resulted in a population fitter than wild-type thanks to the presence of iodotyrosine in its proteome Probing protein localization and protein-protein interaction in bacteria.
Another incident during the war highlighted the question of large-scale Iraqi combat deaths. This was the "bulldozer assault", where two brigades from the US 1st Infantry Division (Mechanized) were faced with a large and complex trench network, as part of the heavily fortified "Saddam Hussein Line". After some deliberation, they opted to use anti-mine plows mounted on tanks and combat earthmovers to simply plow over and bury alive the defending Iraqi soldiers. Not a single American was killed during the attack. Reporters were banned from witnessing the attack, near the neutral zone that touches the border between Saudi Arabia and Iraq. Every American in the assault was inside an armored vehicle. Patrick Day Sloyan of Newsday reported, "Bradley Fighting Vehicles and Vulcan armored carriers straddled the trench lines and fired into the Iraqi soldiers as the tanks covered them with mounds of sand. 'I came through right after the lead company,' [Col. Anthony] Moreno said. 'What you saw was a bunch of buried trenches with peoples' arms and things sticking out of them.'" After the war, the Iraqi government said that only 44 bodies were found. In his book The Wars Against Saddam, John Simpson alleges that US forces attempted to cover up the incident.
=== Use in research === Baculovirus-insect cell expression is a technique used to produce large quantities of a desired protein. It takes advantage of the ability of Baculovirus to insert genes into its target cell and induce protein expression this gene. Numerous insect cells have been developed into cell lines, such as fruit flies, mosquitoes, and silkworms. The tissue of the cabbage looper has also been used to develop a cell line. It is particularly useful for its fast growth rate and less reliance upon insect haemolymph in the medium. The cabbage looper cell line has also been engineered to grow in serum-free media. Although animal serum helps insect cell growth, it is very expensive and can hinder subsequent experimental procedures. As a result, the development of the cell line to grow independently of serum means that the cell line could be used to produce viruses and proteins in a more affordable, efficient, and productive manner.
=== Excitation === In principle, coherent axial oscillations of ion rings could be excited by applying RF waveforms to the outer electrode as demonstrated in and references therein. However, if ion packets are injected away from the minimum of the axial potential (which corresponds to the thickest part of either electrode), this automatically initiates their axial oscillations, eliminating the need for any additional excitation. Furthermore, the absence of additional excitation allows the detection process to start as soon as the detection electronics recover from the voltage ramp needed for ion injection.
Sources: en.wikipedia.org
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.
Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.
No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.